- Home
- HUBS vs PODD Comparison
HUBS vs PODD Comparison
Compare HUBS & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUBS | PODD |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.8B | 22.1B |
| IPO Year | 2014 | 2007 |
Fundamental Metrics
Financial Performance| Metric | HUBS | PODD |
|---|---|---|
| Price | $378.58 | $304.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 30 | 19 |
| Target Price | ★ $626.87 | $359.00 |
| AVG Volume (30 Days) | ★ 833.8K | 765.6K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.45 |
| Revenue | ★ $2,987,698,000.00 | $2,521,800,000.00 |
| Revenue This Year | $20.84 | $32.55 |
| Revenue Next Year | $16.03 | $20.39 |
| P/E Ratio | ★ N/A | $88.24 |
| Revenue Growth | 19.21 | ★ 27.11 |
| 52 Week Low | $344.41 | $230.05 |
| 52 Week High | $881.13 | $354.88 |
Technical Indicators
Market Signals| Indicator | HUBS | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 41.61 | 40.94 |
| Support Level | $364.00 | $303.20 |
| Resistance Level | $381.70 | $317.34 |
| Average True Range (ATR) | 13.79 | 13.12 |
| MACD | 4.30 | -2.82 |
| Stochastic Oscillator | 67.68 | 3.14 |
Price Performance
Historical ComparisonAbout HUBS HubSpot Inc.
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.